ArticleJournal of translational medicine2024

DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors.

Xi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.